Jasmin Zorn
YOU?
Author Swipe
View article: A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022
A longitudinal study on SARS-CoV-2 seroconversion, reinfection and neutralisation spanning several variant waves and vaccination campaigns, Heinsberg, Germany, April 2020 to November 2022 Open
Background Since its emergence in December 2019, over 700 million people worldwide have been infected with SARS-CoV-2 up to May 2024. While early rollout of mRNA vaccines against COVID-19 has saved many lives, there was increasing immune e…
View article: Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin
Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin Open
View article: Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin
Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin Open
Several studies have suggested the imprinting of SARS-CoV-2 immunity by original immune challenge without addressing the formation of the de novo response to successive antigen exposures. As this is crucial for the development of the origi…
View article: SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection
SARS-CoV-2 humoral and cellular immunity following different combinations of vaccination and breakthrough infection Open
View article: Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2
Longitudinal monitoring of mRNA-vaccine-induced immunity against SARS-CoV-2 Open
Background Worldwide vaccination campaigns significantly reduced mortality caused by SARS-CoV-2 infection and diminished the devastating effects of the pandemic. The first approved vaccines are based on novel mRNA technology and elicit pot…
View article: SARS-CoV-2 Immunity following different combinations of vaccination and breakthrough infection
SARS-CoV-2 Immunity following different combinations of vaccination and breakthrough infection Open
The elicited anti-SARS-CoV-2 immunity worldwide is becoming increasingly complex with individuals receiving a different amount of vaccine doses paired with or without recovery from breakthrough infections with different variants. To unders…
View article: Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response Open
To efficiently maintain immunity against SARS-CoV-2 infection, we must first determine the durability of the immune response following infection or vaccination. Here, we demonstrated that, unlike antibodies, virus-specific memory B cells p…
View article: Persistent Maintenance of Atypical Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
Persistent Maintenance of Atypical Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response Open